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ASSESSMENT OF PATIENT-REPORTED OUTCOMES AMONG
OSTEOARTHRITIC PATIENTS
Gandra SR, Lawrence LW
The University of Louisiana at Monroe, Monroe, LA, USA
OBJECTIVE: To compare the psychosocial status, functional
limitations and time off work between osteoarthritic patients
(OAP) and non-OAP in a national sample of US adults.
METHODS: This retrospective study compared perceived health
status (PHS), mental health status (MHS), physical limitations
and time off work in the 2000 Medical Expenditure Panel Survey
(MEPS). Patients 18 years and older who reported having
osteoarthritis (ICD-9-CM = 715) were included. Non-OAP were
randomly matched on age, gender and race with the OAP.
Patients with other and unspeciﬁed disorders of joints (ICD-
9-CM = 719) were selected for further comparison. PHS and
MHS were analyzed using ANCOVA, adjusting for number of
co-morbidities. Odds ratio were estimated using logistic regres-
sion for patient-reported limitations. All analyses used patient
speciﬁc sampling weights provided by MEPS. RESULTS:
Approximately 1.7 million OAP and 1.8 million non-OAP were
identiﬁed. PHS and MHS were reported on a scale of 1 to 5 with
“1” being “excellent” and “5” being “poor”. A lower propor-
tion of OAP (30%) reported having “excellent” or “very good”
health when compared to patients with other diagnoses 
(79%). OAP reported poorer PHS (3.02 vs. 1.94 respectively)
and MHS (2.28 vs. 1.67 respectively) than non-OAP. Mean 
time off work due to illness was higher among OAP than those
with other diagnoses (3.07 vs. 1.83 respectively). OAP have
increased odds of requiring assistance with ADL and IADL (2.19
and 2.07 respectively), while facing increased odds of social lim-
itations (4.01). CONCLUSIONS: Osteoarthritis has a greater
impact on patients’ psychosocial status and their perception of
health. OAP reported more limitations in functional abilities
compared to non-OAP. These ﬁndings indicate that in addition
to clinical efﬁcacy, therapeutic effectiveness should include
patient based outcome measures. Attributes like quality of life,
which are important from the patients’ perspective, should be
emphasized.
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THE RELATIONSHIP BETWEEN GASTROINTESTINAL
SYMPTOMS AND HEALTH-RELATED QUALITY OF LIFE IN
KOREAN PATIENTS WITH RHEUMATIC DISEASES
Bae SC1, Kim S2, Uhm WS1
1Hanyang University, Seoul, Korea, Seoul, South Korea; 2Pochon CHA
University, SeongNam, South Korea
OBJECTIVE: To evaluate the relationship between gastroin-
testinal (GI) symptoms and Health-Related Quality of Life
(HRQoL) in patients with rheumatic diseases. METHODS: A
total of 498 patients visiting outpatient clinics (RA = 98, OA =
99, SLE = 113, FM = 101, AS = 87) completed questionnaires
that measure demographic and clinical characteristics, compli-
ance, GI symptoms and a visual analog scale (VAS: 0-100) for
the GI symptom severity scale. A patient with a particular disease
also completed disease-speciﬁc questionnaires. We used the SF-
36 mental composite score (MCS) as HRQoL score in all analy-
sis. RESULTS: A majority of patients (n = 349; 70.1%) reported
at least one GI symptom. Mean number of symptoms was ranged
from 1.82 (OA) to 4.43 (FM) during last one month. GI sever-
ity scale was ranged from 41.5 (SLE) to 56.3 (FM). Dyspepsia
(58.5%) and heartburn/reﬂux (52.7%) were the most com-
plained GI symptoms. Regarding compliance on GI symptoms,
patients the less forgot, more careful, and less skipped taking
medicine, the less they experienced GI symptoms. Those who
reported GI symptoms had signiﬁcantly lower HRQoL score
than those who did not (56.16,,b25.79 vs. 68.95,,b24.47; p <
0.0001). When evaluating GI factors and non-GI factors on
HRQoL in patients with GI symptoms after adjusting for age,
number of GI symptoms, and GI severity scale, age and number
of GI symptoms were signiﬁcant (both p’s < 0.0001). Each
number of GI symptom increased by 1, predicted SF-36 MCS
decreased by approximately 4 points (p = 0.032) when adjust-
ing for age. CONCLUSIONS: Complied with medication pre-
scribed by a physician, even if the patient feels that their GI
symptoms get worse after taking medicine, is important in order
to reduce number of GI symptoms. The less number of GI symp-
toms the patient experience, the better health-related quality of
life the patient will have.
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HEALTH RELATED QUALITY OF LIFE OF CHRONIC LOW
BACK PAIN AND OSTEOARTHRITIS PATIENTS RECEIVING
FENTANYL TRANSDERMAL SYSTEM
Hamed A1, Huang YH1, Lee A1, Miller DR1, Ren SX1, Iqbal U1,
Vallow S2, Schein J2, Kazis L1
1Boston University, Boston, MA, USA; 2Janssen Pharmaceutica
Products,Titusville, NJ, USA
OBJECTIVES: We studied the effect of length of therapy with
transdermal fentanyl (TDF) on patient reported change in phys-
ical and emotional well-being, and physical and mental compo-
nent summary (PCS and MCS) scores using the Veterans SF-36,
in patients with chronic low back pain and/or osteoarthritis in
the Veterans Health Administration (VHA). METHODS: We
studied 441 VHA patients with 2 or more ICD-9-CM claims for
LBP and/or osteoarthritis over 3 months, who responded to a
1999 national survey assessing health-related quality of life and
receiving TDF within 60 days of the survey. Three therapeutic
groups were identiﬁed: TDF-only users, switchers-to-TDF and
users of TDF with short-acting opioids. PCS, MCS, and physi-
cal change and emotional change items were derived from the
Veterans SF-36. Multivariate models were developed with the
following dependant variables: physical change item, mental
change item, physical component summary score, and mental
component summary score. Baseline covariate adjustments
included TDF patch duration, therapeutic groups, age, race, dis-
ability categorization, number of physical co-morbidities, and
depression. RESULTS: Average age was 60 (SD 13), 95% were
male, 76% were white, 61% were married, 5% were employed,
and 38 % were priority group 1 (50% or more service connected
disability). Patients had an average of 3.3 (SD 2.6) medical con-
ditions, 1.1 (SD 1.3) mental conditions, and 40% had depres-
sion. Multivariate models showed that TDF was associated with
an improvement in physical change of 0.09/month (p < 0.0004),
reaching a one-half standard deviation improvement (moderate
effect size) in 5 months, and a 0.05 (p < 0.049)/month improve-
ment in emotional change compared to a year ago. Each extra
month on TDF was associated with 0.72 (p = 0.02) improvement
in MCS, while there was no signiﬁcant effect on PCS. CON-
CLUSION: Results suggest that patients receiving TDF report
improvement in their physical and emotional status compared to
a year ago.
